Journal article

Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population

Sandy Tun Min, Aflah Roohullah, Annette Tognela, Azim Jalali, Margaret Lee, Rachel Wong, Jeremy Shapiro, Matthew Burge, Desmond Yip, Louise Nott, Allan Zimet, Belinda Lee, Andrew Dean, Simone Steel, Hui-Li Wong, Peter Gibbs, Stephanie Hui-Su Lim



BACKGROUND: Colorectal cancer is the third most common cancer and second leading cause of cancer mortality in Australia, thus carrying a significant disease burden. AIMS: This analysis aims to explore real-world treatment landscape of metastatic colorectal cancer in the third-line setting. METHODS: We retrospectively analysed treatment of recurrent and advanced colorectal cancer (TRACC) registry database from 2009 onwards. Patients treated with palliative intent who progressed after two lines of therapies were included. One treatment line was defined as any combination of systemic therapy given until progression. RESULTS: Out of 1820 patients treated palliatively, 32% (590 patients) met stud..

View full abstract


Funding Acknowledgements

The TRACCdatabase is supported by RocheProductsPty Limited (Australia). Roche has provided financial assistance for the development, installation and maintenance of this clinical database. The authors would like to thank Michael Harold and Julie Johns for assistance with data extractions.